Fava speaks at Genomics England Research Summit

Videha spoke on a panel about population genomics and the future of genomic healthcare.

The summit brought together leaders from research, healthcare, industry, policy and patient engagement to explore how genomics can move from specialist services and research programmes into the fabric of everyday healthcare.

This year’s discussions reflected a growing national focus on genomics, with major UK strategies including the 10 Year Health Plan and the Life Sciences Sector Plan placing genomics at the centre of future healthcare and innovation.

Population genomics has the potential to support prevention, earlier diagnosis, safer prescribing and more personalised care at scale.

The challenge is implementation. Genomic data needs to be translated into services that are trusted by the public, usable by clinicians and embedded into routine healthcare systems.

This aligns closely with work we recently delivered on public and healthcare professional perspectives on population genomics. That work highlighted the importance of trusted clinical messengers, clear communication, inclusive engagement and user-centred service design. These are the foundations needed to build genomic services that people understand, trust and can use in real life.

[Insert link to case study: Understanding perspectives on population genomics]

For us, this is exactly where Fava sits: helping health systems turn genomic insight into practical tools, workflows and services that can support real clinical action.

Speaking at the summit gave us the opportunity to contribute to a national conversation about how population genomics should be designed and delivered.

On the panel, Videha focused on the practical enablers that will determine whether genomic programmes succeed in the real world: co-design with patients and healthcare professionals, digital infrastructure that fits into clinical workflows, and public trust built through transparency, governance and meaningful engagement.

These themes are central to our work at Fava, from returning pharmacogenomic results to participants and patients, to building digital tools that help clinicians use genomic information in everyday care.

As genomics becomes a bigger part of national health strategy, the focus now needs to shift from ambition to delivery.

We are continuing to work with healthcare, research and industry partners to build the infrastructure, content and services needed to make genomics part of everyday care.

The Genomics England Research Summit was a clear reminder that the opportunity is significant. The impact will depend on how well we design, deliver and embed genomic services into the healthcare systems people already use.